Cargando…
Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule
Recently, several chemotherapeutic drugs have been repositioned in neurological diseases, based on common biological backgrounds and the inverse comorbidity between cancer and neurodegenerative diseases. Fenretinide (all-trans-N-(4-hydroxyphenyl) retinamide, 4-HPR) is a synthetic derivative of all-t...
Autores principales: | Potenza, Rosa Luisa, Lodeserto, Pietro, Orienti, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266536/ https://www.ncbi.nlm.nih.gov/pubmed/35806431 http://dx.doi.org/10.3390/ijms23137426 |
Ejemplares similares
-
Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment in COVID-19
por: Orienti, Isabella, et al.
Publicado: (2020) -
Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model
por: Durante, Sandra, et al.
Publicado: (2014) -
The “Janus Face” of Platelets in Cancer
por: Catani, Maria Valeria, et al.
Publicado: (2020) -
Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor
por: Orienti, Isabella, et al.
Publicado: (2020) -
Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines
por: Lodeserto, Pietro, et al.
Publicado: (2022)